We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0QK8 market cap is 0. The company's latest EPS is USD 5.2353 and P/E is 7.52.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.5B | 11.69B | 12.79B | 15.11B | 14.84B |
| Operating Income | 1.77B | 1.62B | 1.71B | -1.94B | 390M |
| Net Income | 1B | 1.1B | 1.28B | -2.43B | 2.66B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.19B | 20.02B | 33.52B | 28.29B | 28.28B |
| Total Liabilities | 10.28B | 11.29B | 24.4B | 22.39B | 19.81B |
| Total Equity | 7.91B | 8.73B | 9.12B | 5.9B | 8.47B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.1B | 1.87B | 2.22B | 1.21B | 1.73B |
| Investing | -1.1B | -1.18B | -11.2B | -931M | 3.21B |
| Financing | 498M | -345M | 8.25B | -1.44B | -3.49B |
| Market Cap | 0 |
| Price to Earnings Ratio | 7.52 |
| Price to Sales Ratio | 1.35 |
| Price to Cash Ratio | 6.26 |
| Price to Book Ratio | 2.36 |
| Dividend Yield | - |
| Shares Outstanding | 507.32M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Baxter International Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.baxter.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
